We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWW icon
301
W.W. Grainger
GWW
$65.3B
$962K 0.02%
4,278
BAP icon
302
Credicorp
BAP
$30.9B
$958K 0.02%
6,296
+981
+18% +$155K
THS
303
DELISTED
Treehouse Foods
THS
$950K 0.02%
10,895
-325
-3% -$31.2K
ZBH icon
304
Zimmer Biomet
ZBH
$17.7B
$947K 0.02%
7,504
+88
+1% +$10.9K
BWLD
305
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$944K 0.02%
6,709
-464
-6% -$72.2K
LYB icon
306
LyondellBasell Industries
LYB
$19.5B
$937K 0.02%
11,615
-5,589
-32% -$432K
LVS icon
307
Las Vegas Sands
LVS
$30.5B
$934K 0.02%
16,240
-1,701
-9% -$87.7K
CLB icon
308
Core Laboratories
CLB
$538M
$926K 0.02%
8,248
-725
-8% -$83.5K
VIG icon
309
Vanguard Dividend Appreciation ETF
VIG
$111B
$924K 0.02%
11,014
-457
-4% -$38.7K
PHO icon
310
Invesco Water Resources ETF
PHO
$1.97B
$919K 0.02%
37,338
-2,775
-7% -$67.3K
USB icon
311
US Bancorp
USB
$99.6B
$919K 0.02%
21,434
+26
+0.1% +$1.1K
LDL
312
DELISTED
Lydall, Inc.
LDL
$918K 0.02%
17,947
+580
+3% +$27.2K
RSPP
313
DELISTED
RSP Permian, Inc.
RSPP
$910K 0.02%
23,470
+172
+0.7% +$6.36K
CP icon
314
Canadian Pacific Kansas City
CP
$82B
$895K 0.02%
29,300
+750
+3% +$22K
XLP icon
315
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$895K 0.02%
16,823
+12,472
+287% +$679K
LLTC
316
DELISTED
Linear Technology Corp
LLTC
$888K 0.02%
14,978
EMR icon
317
Emerson Electric
EMR
$82.9B
$886K 0.02%
16,263
+1,001
+7% +$53.6K
IBTX
318
DELISTED
Independent Bank Group, Inc.
IBTX
$878K 0.02%
19,889
+1,244
+7% +$53.5K
TSLX icon
319
Sixth Street Specialty
TSLX
$1.59B
$861K 0.02%
47,564
+5,528
+13% +$98.7K
ARI
320
Apollo Commercial Real Estate
ARI
$887M
$838K 0.02%
51,191
+7,046
+16% +$116K
WY icon
321
Weyerhaeuser
WY
$17.3B
$836K 0.02%
26,176
-8,073
-24% -$255K
LOPE icon
322
Grand Canyon Education
LOPE
$3.71B
$835K 0.02%
20,664
-980
-5% -$40.7K
OXY icon
323
Occidental Petroleum
OXY
$57B
$835K 0.02%
11,458
+2,826
+33% +$212K
LAZ icon
324
Lazard
LAZ
$4.37B
$833K 0.02%
22,920
-310
-1% -$10.8K
RSP icon
325
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$832K 0.02%
9,948
+4,747
+91% +$395K

Similar funds

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.